Category: Legal Press releases

2022-05-31 Legal Press releases

Strangvac, a vaccine against equine strangles, available for sale in Denmark

Stockholm, May 31, 2022 - Intervacc announces today that Strangvac®, a vaccine against the highly contagious infectious disease equine strangles, has been released for sale in Denmark.

2022-05-20 Legal Press releases

Interim report January – March 2022

The period in summary

First quarter January 1 – March 31, 2022

On March 23 the first batch of Strangvac ... Read more

2022-05-19 Legal Press releases

Intervacc progresses vaccine to prevent mastitis in dairy cows caused by Staphylococcus aureus

Stockholm, May 19, 2022 - Intervacc AB (publ) announces the initiation of a proof-of-concept study to measure the effectiveness of a vaccine to protect dairy cows against mastitis caused by Staphylococcus ... Read more

2022-05-11 Legal Press releases

Notice of annual general meeting in Intervacc AB (publ)

The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on Tuesday 14 June 2022 at 5.00 p.m. at Good Morning Hotel, ... Read more

2022-04-25 Legal Press releases

Positive results in proof-of-concept study to develop a vaccine against Streptococcus suis infection in pigs

Stockholm, April 25, 2022 - Intervacc AB (publ) announces positive results from a proof-of-concept study where piglets from vaccinated sows were protected against experimental challenge with Streptococcus ... Read more

2022-04-06 Legal Press releases

Intervacc publishes the 2021 Annual Report

Stockholm, April 6, 2022 - Intervacc AB (publ) announces that the company's 2021 Annual Report has been published today. The annual report (in Swedish) is attached and an English unaudited translation of the report is ... Read more

« Previous 1 … 14 15 16 17 18 … 25 Next »

Postal address:

Västertorpsvägen 135 B,
SE-129 44 Hägersten

Phone: 08-120 10 600

Fax: 08-120 10 640

Email: info@intervacc.se